Invest A/s Lundbeckfond - 07 Nov 2023 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Reporting relationship: 10%+ Owner
Issuer ticker: LXEO
Reported as of: 07 Nov 2023
Net transaction value: +$2,499,992
SEC form: 4
Accepted by SEC: 09 Nov 2023, 20:33:54 UTC
Prior SEC filing: 02 Nov 2023
Source filing: View source filing
Reporting owner signature: /s/ Christian E. Elling, Managing Partner and /s/ Lene Skole, Chief Executive Officer

Key filing fact

Invest A/s Lundbeckfond filed Form 4 for Lexeo Therapeutics, Inc. (LXEO) on 09 Nov 2023.

Key facts

This page summarizes Invest A/s Lundbeckfond's Form 4 filing for Lexeo Therapeutics, Inc. (LXEO).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Nov 2023, 20:33.

Change

Previous filing in this sequence was filed on 02 Nov 2023.
Current net transaction value: +$2,499,992.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LXEO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,321,474
Change %
Price
Shares after: 1,321,474
Date: 07 Nov 2023
Ownership: Direct
Footnotes: F1

LXEO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +287,213
Change %: +22%
Price
Shares after: 1,608,687
Date: 07 Nov 2023
Ownership: Direct
Footnotes: F2

LXEO transaction

Common Stock

Purchase

Transaction value: $2,499,992
Shares: +227,272
Change %: +14%
Price: $11.00^*
Shares after: 1,835,959
Date: 07 Nov 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LXEO transaction Derivative

Series A convertible preferred stock

Conversion of derivative security

Transaction value
Shares: -13,999,999
Change %: -100%
Price
Shares after: 0
Date: 07 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,321,474
Exercise price
Footnotes: F1

LXEO transaction Derivative

Series B convertible preferred stock

Conversion of derivative security

Transaction value
Shares: -2,615,533
Change %: -100%
Price
Shares after: 0
Date: 07 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 287,213
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Invest A/s Lundbeckfond is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date.

Footnote F2

Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date.